Crossmark

ePROs in the follow-up of cancer patients treated with immune checkpoint inhibitors: a retrospective study

Crossref DOI link: https://doi.org/10.1007/s00432-018-02835-6

Published Online: 2019-01-21

Published Print: 2019-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Iivanainen, Sanna

Alanko, Tuomo

Peltola, Katriina

Konkola, Teemu

Ekström, Jussi

Virtanen, Henri

Koivunen, Jussi P. https://orcid.org/0000-0001-6425-1640
License Information

Text and Data Mining valid from 2019-01-21
More Information

Article History

Received: 19 November 2018

Accepted: 24 December 2018

First Online: 21 January 2019

Compliance with ethical standards

:

: SI and KP declare that they have no competing interests. TK, JE, and HV are employees of Kaiku Health, and HV owns stock in Kaiku Health. JPK and TA are advisors for Kaiku Health.

: According to national legislation, informed consent is not needed due to the retrospective and non-interventional nature of the study.

: The data sets generated and/or analyzed during the current study are not publicly available but are available from the corresponding author on reasonable request.